Crinetics Pharmaceuticals, Inc.
CRNXDelisted Sep 1, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001658247
Crinetics Pharmaceuticals, Inc. was delisted on Sep 1, 2026; its insiders filed their last Form 4 on Sep 1, 2026; 267 institutions reported holding it in 13F filings for Q2 2026, worth $4.63B in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Crinetics Pharmaceuticals, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 181
- +10 vs. Q3 2023
- Shares held
- 70.7M
- +2.16M (+3.2%) vs. Q3 2023
- Total value
- $2.51B
- +$476.1M (+23.4%) vs. Q3 2023
- New holders
- 34
- 75 more added
- Sold out
- 24
- 58 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 267 | $4.63B |
| Q1 2026 | 244 | $4.46B |
| Q4 2025 | 242 | $5.20B |
| Q3 2025 | 225 | $4.49B |
| Q2 2025 | 222 | $3.01B |
| Q1 2025 | 227 | $3.42B |
| Q4 2024 | 247 | $5.10B |
| Q3 2024 | 235 | $4.32B |
| Q2 2024 | 234 | $3.69B |
| Q1 2024 | 203 | $3.76B |
| Q4 2023 | 181 | $2.51B |
| Q3 2023 | 172 | $2.04B |
| Q2 2023 | 140 | $974.1M |
| Q1 2023 | 129 | $884.3M |
| Q4 2022 | 122 | $1.00B |
| Q3 2022 | 122 | $1.01B |
| Q2 2022 | 111 | $944.5M |
| Q1 2022 | 116 | $997.4M |
| Q4 2021 | 118 | $1.26B |
| Q3 2021 | 94 | $708.2M |
| Q2 2021 | 83 | $616.9M |
| Q1 2021 | 80 | $465.3M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Crinetics Pharmaceuticals, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 67,293 | $2.39M | 0.02% | −209,915−75.7% | Reduced |
| First Trust Advisors LP | 73,457 | $2.61M | 0.00% | +73,457 | New |
| Alyeska Investment Group, L.P. | 76,575 | $2.72M | 0.02% | +7,073+10.2% | Added |
| Deutsche Bank AG | 80,427 | $2.86M | 0.00% | +50,217+166.2% | Added |
| Manufacturers Life Insurance Company, The | 80,966 | $2.88M | 0.00% | +17,083+26.7% | Added |
| Acuta Capital Partners, LLC | 87,500 | $3.11M | 1.75% | −6,500−6.9% | Reduced |
| JPMorgan Chase & Co | 93,104 | $3.31M | 0.00% | +38,674+71.1% | Added |
| Lisanti Capital Growth, LLC | 100,245 | $3.57M | 0.84% | +50,265+100.6% | Added |
| Standard Life Aberdeen plc | 101,196 | $3.60M | 0.01% | +101,196 | New |
| Citigroup Inc | 102,311 | $3.64M | 0.00% | +18,539+22.1% | Added |
| Jane Street Group, LLC | 103,034 | $3.67M | 0.00% | +90,222+704.2% | Added |
| Swiss National Bank | 104,200 | $3.71M | 0.00% | −12,200−10.5% | Reduced |
| EAM Investors, LLC | 105,005 | $3.74M | 0.67% | +10,816+11.5% | Added |
| Rhumbline Advisers | 107,215 | $3.81M | 0.00% | +661+0.6% | Added |
| Simplify Asset Management Inc. | 115,000 | $4.09M | 0.63% | 00.0% | Unchanged |
| Pier Capital, LLC | 116,603 | $4.15M | 0.59% | +116,603 | New |
| Parkman Healthcare Partners LLC | 120,652 | $4.29M | 0.61% | +20,652+20.7% | Added |
| Farallon Capital Management, L.L.C. | 122,904 | $4.37M | 0.03% | −239,000−66.0% | Reduced |
| ExodusPoint Capital Management, LP | 127,682 | $4.54M | 0.06% | +98,743+341.2% | Added |
| Prudential Financial Inc | 136,945 | $4.87M | 0.01% | +4,316+3.3% | Added |
| UBS Group AG | 138,465 | $4.93M | 0.00% | +56,607+69.2% | Added |
| New Leaf Venture Partners, L.L.C. | 141,000 | $5.02M | 4.04% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 144,911 | $5.16M | 0.19% | −22,327−13.4% | Reduced |
| Woodline Partners LP | 150,000 | $5.34M | 0.06% | 00.0% | Unchanged |
| Propel Bio Management, LLC | 165,000 | $5.87M | 4.87% | +165,000 | New |
| Invesco Ltd. | 171,837 | $6.11M | 0.00% | −5,536−3.1% | Reduced |
| TD Asset Management Inc | 176,426 | $6.28M | 0.01% | +37,000+26.5% | Added |
| BNP Paribas Arbitrage, SA | 180,495 | $6.42M | 0.01% | −123,625−40.7% | Reduced |
| Victory Capital Management Inc | 184,107 | $6.55M | 0.01% | +139,117+309.2% | Added |
| Barclays PLC | 190,984 | $6.80M | 0.00% | +77,702+68.6% | Added |
| Two Sigma Investments, LP | 193,101 | $6.87M | 0.02% | −208,852−52.0% | Reduced |
| Integral Health Asset Management, LLC | 200,000 | $7.12M | 1.03% | 00.0% | Unchanged |
| Rafferty Asset Management, LLC | 244,289 | $8.69M | 0.04% | +46,548+23.5% | Added |
| StemPoint Capital LP | 249,575 | $8.88M | 2.39% | +249,575 | New |
| Walleye Capital LLC | 269,088 | $9.57M | 0.13% | −165,822−38.1% | Reduced |
| Candriam Luxembourg S.C.A. | 288,011 | $10.2M | 0.07% | +288,011 | New |
| Opaleye Management Inc. | 307,500 | $10.9M | 2.94% | −62,500−16.9% | Reduced |
| Bank of New York Mellon Corp | 329,579 | $11.7M | 0.00% | −162,468−33.0% | Reduced |
| Bank of America Corp | 344,413 | $12.3M | 0.00% | +189,513+122.3% | Added |
| Vivo Capital, LLC | 350,000 | $12.5M | 1.02% | 00.0% | Unchanged |
| Millennium Management LLC | 373,629 | $13.3M | 0.01% | +91,030+32.2% | Added |
| Frazier Life Sciences Management, L.P. | 397,483 | $14.1M | 0.76% | −1,192,448−75.0% | Reduced |
| Franklin Resources Inc | 413,209 | $14.7M | 0.01% | +274,384+197.6% | Added |
| Ensign Peak Advisors, Inc | 435,685 | $15.5M | 0.03% | +51,000+13.3% | Added |
| Fisher Asset Management, LLC | 441,295 | $15.7M | 0.01% | +387,435+719.3% | Added |
| Affinity Asset Advisors, LLC | 447,095 | $15.9M | 3.17% | −2,905−0.6% | Reduced |
| Vestal Point Capital, LP | 450,000 | $16.0M | 1.70% | +450,000 | New |
| Charles Schwab Investment Management Inc | 470,373 | $16.7M | 0.00% | +9,070+2.0% | Added |
| MPM Oncology Impact Management LP | 478,234 | $17.0M | 3.98% | −819−0.2% | Reduced |
| GW&K Investment Management, LLC | 479,063 | $17.0M | 0.16% | −3,879−0.8% | Reduced |
| Avidity Partners Management LP | 529,000 | $18.8M | 0.72% | −81,000−13.3% | Reduced |
| Janus Henderson Group PLC | 543,263 | $19.3M | 0.01% | −45,115−7.7% | Reduced |
| Laurion Capital Management LP | 568,982 | $20.2M | 0.73% | +222,345+64.1% | Added |
| Northern Trust Corp | 602,422 | $21.4M | 0.00% | +5,098+0.9% | Added |
| Morgan Stanley | 648,251 | $23.1M | 0.00% | +136,930+26.8% | Added |
| Goldman Sachs Group Inc | 650,173 | $23.1M | 0.01% | +97,575+17.7% | Added |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 658,289 | $23.4M | 0.07% | +24,925+3.9% | Added |
| Dimensional Fund Advisors LP | 659,921 | $23.5M | 0.01% | −84,895−11.4% | Reduced |
| Nuveen Asset Management, LLC | 679,171 | $24.2M | 0.01% | +268,230+65.3% | Added |
| Ikarian Capital, LLC | 680,370 | $24.2M | 6.62% | −112,550−14.2% | Reduced |
| Lord, Abbett & Co. LLC | 777,288 | $27.7M | 0.10% | +777,288 | New |
| Saturn V Capital Management LLC | 787,132 | $28.0M | 10.72% | −339,447−30.1% | Reduced |
| Eventide Asset Management, LLC | 1,059,633 | $37.7M | 0.62% | +40,851+4.0% | Added |
| Novo Holdings A/S | 1,100,000 | $39.1M | 2.62% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,150,000 | $40.9M | 1.96% | +48,096+4.4% | Added |
| Perceptive Advisors LLC | 1,255,512 | $44.7M | 1.00% | −8,220−0.7% | Reduced |
| Geode Capital Management, LLC | 1,352,672 | $48.1M | 0.01% | +82,998+6.5% | Added |
| OrbiMed Advisors LLC | 1,667,360 | $59.3M | 1.19% | −1,228,714−42.4% | Reduced |
| First Light Asset Management, LLC | 1,987,772 | $70.7M | 5.69% | +404,443+25.5% | Added |
| EcoR1 Capital, LLC | 2,012,517 | $71.6M | 1.86% | +482,254+31.5% | Added |
| Paradigm Biocapital Advisors LP | 2,312,919 | $82.3M | 3.86% | +134,182+6.2% | Added |
| T. Rowe Price Investment Management, Inc. | 2,417,493 | $86.0M | 0.06% | +776,801+47.3% | Added |
| Jennison Associates LLC | 2,547,683 | $90.6M | 0.07% | +1,113,992+77.7% | Added |
| Price T Rowe Associates Inc | 3,008,858 | $107.1M | 0.01% | +430,659+16.7% | Added |
| Wellington Management Group LLP | 3,245,105 | $115.5M | 0.02% | −395,130−10.9% | Reduced |
| Point72 Asset Management, L.P. | 3,416,900 | $121.6M | 0.37% | −808,400−19.1% | Reduced |
| Vanguard Group Inc | 3,502,452 | $124.6M | 0.00% | +95,417+2.8% | Added |
| State Street Corp | 3,563,736 | $126.8M | 0.01% | +711,016+24.9% | Added |
| FMR LLC | 4,043,865 | $143.9M | 0.01% | +1,903,004+88.9% | Added |
| Driehaus Capital Management LLC | 5,039,957 | $179.3M | 2.16% | −92,330−1.8% | Reduced |
| BlackRock Inc. | 5,345,114 | $190.2M | 0.00% | +499,397+10.3% | Added |
| Bain Capital Life Sciences Investors, LLC | 0 | $0 | 0.00% | −1,275,552−100.0% | Sold out |
| Commodore Capital LP | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| 5AM Venture Management, LLC | 0 | $0 | 0.00% | −462,286−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −220,000−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −152,200−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −82,000−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −63,917−100.0% | Sold out |
| Moody Aldrich Partners LLC | 0 | $0 | 0.00% | −61,979−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −51,629−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −44,377−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −31,720−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −29,500−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −27,371−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −23,082−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −17,893−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −13,874−100.0% | Sold out |